Enzrid 90mg/48mg/100mg Tablet is a combination pharmaceutical formulation containing Bromelain (90mg), Trypsin (48mg), and Rutoside (100mg), designed to provide anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby aiding in the reduction of inflammation and edema. Trypsin, another proteolytic enzyme, complements bromelain by enhancing the degradation of inflammatory mediators and promoting tissue repair. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, contributing to improved microcirculation and reduced vascular permeability. The synergistic action of these components makes Enzrid effective in managing conditions characterized by inflammation, swelling, and impaired circulation, such as postoperative edema, trauma, and chronic venous insufficiency. It is commonly prescribed as an adjunct therapy to accelerate recovery, alleviate pain, and improve tissue healing. Enzrid should be used under medical supervision, with consideration given to contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Adherence to recommended dosage and monitoring for adverse effects, including gastrointestinal discomfort or allergic reactions, is essential to ensure therapeutic efficacy and patient safety.